Evidence map›Paper›PMID 34316670›Full record

ArticleClinical parkinsonism & related disorders2021

Solvent exposed occupations and risk of Parkinson disease in Finland.

Susan Searles Nielsen, Mark N Warden, Markku Sallmén, Markku Sainio, Sanni Uuksulainen, Harvey Checkoway, Christer Hublin, Brad A Racette

Open access · goldAbstract read
In one paragraph

Article in Clinical parkinsonism & related disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Update: Protective and risk factors for Parkinson disease.Parkinsonism & related disorders · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Preventing Parkinson's Disease: An Environmental Agenda.Journal of Parkinson's disease · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Susan Searles NielsenWashington University School of Medicine in St. Louis, Department of Neurology, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
Mark N WardenWashington University School of Medicine in St. Louis, Department of Neurology, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
Markku SallménFinnish Institute of Occupational Health, PO Box 18, FI-00032 Tyoterveyslaitos, Arinatie 3 A, 00370 Helsinki, Finland.
Markku SainioFinnish Institute of Occupational Health, PO Box 18, FI-00032 Tyoterveyslaitos, Arinatie 3 A, 00370 Helsinki, Finland.
Sanni UuksulainenFinnish Institute of Occupational Health, PO Box 18, FI-00032 Tyoterveyslaitos, Arinatie 3 A, 00370 Helsinki, Finland.
Harvey CheckowayUniversity of California, San Diego, Herbert Wertheim School of Public Health, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Christer HublinFinnish Institute of Occupational Health, PO Box 18, FI-00032 Tyoterveyslaitos, Arinatie 3 A, 00370 Helsinki, Finland.
Brad A RacetteWashington University School of Medicine in St. Louis, Department of Neurology, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
Finnish Institute of Occupational Health · FIWashington University in St. Louis · USUniversity of California San Diego · USUniversity of the Witwatersrand · ZA

Funding

Epidemiology and Biomarkers of Parkinsonism in WeldersK24ES017765 · NIEHS · WASHINGTON UNIVERSITY · PI RACETTE, BRAD A · 2009 to 2018
$1.5M
A Nationwide Study of Environmental Risk Factors for Parkinson DiseaseK01ES028295 · NIEHS · WASHINGTON UNIVERSITY · PI SEARLES NIELSEN, SUSAN · 2018 to 2020
$450k
Risk of Parkinson Disease Associated with Solvent Exposures in FinlandR21ES024120 · NIEHS · WASHINGTON UNIVERSITY · PI RACETTE, BRAD A · 2014 to 2015
$381k
NIEHS NIH HHS K01 ES028295NIEHS NIH HHS K24 ES017765NIEHS NIH HHS R21 ES024120
6 · The paper itself

Abstract

introductionEpidemiologic and toxicology studies suggest that exposure to various solvents, especially chlorinated hydrocarbon solvents, might increase Parkinson disease (PD) risk.

methodsIn a population-based case-control study in Finland, we examined whether occupations with potential for solvent exposures were associated with PD. We identified newly diagnosed cases age 45-84 from a nationwide medication reimbursement register in 1995-2014. From the population register, we randomly selected non-PD controls matched on sex, along with birth and diagnosis years (age). We included 11,757 cases and 23,236 controls with an occupation in the 1990 census, corresponding to age 40-60. We focused on 28 occupations with ≥ 5% probability of solvent exposure according to the Finnish Job Exposure Matrix. We estimated odds ratios (ORs) and 95% confidence intervals (CIs) by logistic regression modeling, adjusting for age, sex, socioeconomic status, and smoking probability.

resultsSimilar proportions of cases (5.5%) and controls (5.6%) had an occupation with potential exposure to any solvents. However, all occupations with a point estimate above one, and all significantly or marginally significantly associated with PD (electronic/telecommunications worker [OR = 1.63, 95% CI 1.05-2.50], laboratory assistant [OR = 1.40, 95% CI 0.98-1.99], and machine/engine mechanic [OR = 1.23, 95% CI 0.99-1.52]) entailed potential for exposure to chlorinated hydrocarbon solvents, specifically. Secondary analyses indicated exposure to polycyclic aromatic hydrocarbons and some metals might contribute to the association for mechanics.

conclusionPD risk might be slightly increased in occupations with potential exposure to chlorinated hydrocarbon solvents. Confirmation is required in additional studies that adjust for other occupational exposures and smoking.

Indexed as

1,1,1-trichloroethaneMethylene chlorideParkinson diseaseSolventsTrichloroethylene

Identifiers

PMID34316670
PMCPMC8299961
OpenAlexW3155396407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.